DE19749197A1 - Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe - Google Patents

Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe

Info

Publication number
DE19749197A1
DE19749197A1 DE19749197A DE19749197A DE19749197A1 DE 19749197 A1 DE19749197 A1 DE 19749197A1 DE 19749197 A DE19749197 A DE 19749197A DE 19749197 A DE19749197 A DE 19749197A DE 19749197 A1 DE19749197 A1 DE 19749197A1
Authority
DE
Germany
Prior art keywords
thrombomodulin
thrombin
protein
sample
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19749197A
Other languages
German (de)
English (en)
Inventor
Michael Dr Kraus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Dade Behring Marburg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg GmbH filed Critical Dade Behring Marburg GmbH
Priority to DE19749197A priority Critical patent/DE19749197A1/de
Priority to EP98118971A priority patent/EP0915340B1/de
Priority to DE59813326T priority patent/DE59813326D1/de
Priority to ES98118971T priority patent/ES2255121T3/es
Priority to AT98118971T priority patent/ATE315233T1/de
Priority to JP31551198A priority patent/JP4361980B2/ja
Priority to CA2252983A priority patent/CA2252983C/en
Priority to AU91397/98A priority patent/AU751525B2/en
Priority to US09/187,035 priority patent/US20020019021A1/en
Publication of DE19749197A1 publication Critical patent/DE19749197A1/de
Priority to US10/419,104 priority patent/US20030207343A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7452—Thrombomodulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19749197A 1997-11-07 1997-11-07 Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe Ceased DE19749197A1 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE19749197A DE19749197A1 (de) 1997-11-07 1997-11-07 Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe
EP98118971A EP0915340B1 (de) 1997-11-07 1998-10-07 Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe und Verfahren zur Bestimmung der Glykosilierung von Thrombomodulin
DE59813326T DE59813326D1 (de) 1997-11-07 1998-10-07 Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe und Verfahren zur Bestimmung der Glykosilierung von Thrombomodulin
ES98118971T ES2255121T3 (es) 1997-11-07 1998-10-07 Procedimiento para la determinacion del potencial anticoagulante de una muestra y procedimiento para la determinacion de la glicosilacion de trombomodulina.
AT98118971T ATE315233T1 (de) 1997-11-07 1998-10-07 Verfahren zur bestimmung des antikoagulatorischen potentials einer probe und verfahren zur bestimmung der glykosilierung von thrombomodulin
JP31551198A JP4361980B2 (ja) 1997-11-07 1998-11-06 サンプルの潜在的抗血液凝固能の測定法
CA2252983A CA2252983C (en) 1997-11-07 1998-11-06 Method for determining the anticoagulatory potential of a sample
AU91397/98A AU751525B2 (en) 1997-11-07 1998-11-06 Method for determining the anticoagulatory potential of a sample
US09/187,035 US20020019021A1 (en) 1997-11-07 1998-11-06 Method for determining the anticoagulatory potential of a sample
US10/419,104 US20030207343A1 (en) 1997-11-07 2003-04-21 Method for determining the anticoagulatory potential of a sample

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19749197A DE19749197A1 (de) 1997-11-07 1997-11-07 Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe

Publications (1)

Publication Number Publication Date
DE19749197A1 true DE19749197A1 (de) 1999-05-12

Family

ID=7847900

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19749197A Ceased DE19749197A1 (de) 1997-11-07 1997-11-07 Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe
DE59813326T Expired - Lifetime DE59813326D1 (de) 1997-11-07 1998-10-07 Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe und Verfahren zur Bestimmung der Glykosilierung von Thrombomodulin

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59813326T Expired - Lifetime DE59813326D1 (de) 1997-11-07 1998-10-07 Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe und Verfahren zur Bestimmung der Glykosilierung von Thrombomodulin

Country Status (8)

Country Link
US (2) US20020019021A1 (enExample)
EP (1) EP0915340B1 (enExample)
JP (1) JP4361980B2 (enExample)
AT (1) ATE315233T1 (enExample)
AU (1) AU751525B2 (enExample)
CA (1) CA2252983C (enExample)
DE (2) DE19749197A1 (enExample)
ES (1) ES2255121T3 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022852A3 (en) * 2000-09-13 2003-04-10 Affinity Biolog Inc Method for measuring antithrombin activity
WO2014020183A1 (de) 2012-08-03 2014-02-06 Ici Immunochemical Intelligence Gmbh In-vitro-assay zur diagnose von störungen der hämostase

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0947585T3 (da) * 1998-03-19 2001-10-01 Instrumentation Lab Spa Forbedret in vitro-fremgangsmåde, kits og reagenser til screening for blodkoagulationsdefekter
WO2001098782A1 (fr) * 2000-06-22 2001-12-27 Mochida Pharmaceutical Co., Ltd Kit de determination du pouvoir de coagulation du sang
US6448024B1 (en) 2000-10-03 2002-09-10 Roche Diagnostics Corporation Method, reagent, cartridge, and device for determining fibrinogen
US6743596B1 (en) 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US6645768B1 (en) 2000-10-27 2003-11-11 Biomerieux, Inc. Reagent and kit for determining global coagulability and hemostatic potential
EP1367135A1 (en) * 2002-05-29 2003-12-03 Pentapharm AG Improved method for the assessment of thrombin formation in blood or plasma
WO2005031303A2 (en) * 2003-09-22 2005-04-07 University Of North Carolina At Chapel Hill Soluble phospholipids for use in clotting factor assays
US20050221414A1 (en) * 2004-03-31 2005-10-06 Katalin Varadi Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
WO2006088741A2 (en) * 2005-02-16 2006-08-24 The Board Of Trustees Of The University Of Illinois Procoagulants based on metal-chelating lipids
EP1869082B1 (en) * 2005-03-04 2011-04-13 The Board Of Trustees Of The University Of Illinois Coagulation and fibrinolytic cascades modulator
GB2433592A (en) * 2005-12-23 2007-06-27 Pentapharm Ag Assay for thrombin inhibitors
WO2009046194A2 (en) 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
JP2009198506A (ja) * 2009-04-10 2009-09-03 Shino Test Corp 血液凝固反応抑制血漿タンパク質の活性測定方法及び活性測定試薬
EP2619540B1 (en) * 2010-09-20 2018-03-21 Q-Sera Pty Ltd Serum preparation
JP5818299B2 (ja) * 2010-12-27 2015-11-18 国立大学法人名古屋大学 凝固因子として作用する異常トロンビンのためのトロンビン不活化動態測定方法
CN103688177B (zh) * 2011-06-17 2017-07-04 学校法人东日本学园 狼疮抗凝物检测用血液凝固时间的测定方法
CN104374621A (zh) * 2014-11-03 2015-02-25 温州市倍可特医疗器械有限公司 用于血液采集容器的血液促凝剂及其制备方法和应用
WO2016172291A1 (en) * 2015-04-23 2016-10-27 Fermi Research Alliance, Llc Monocrystal-based microchannel plate image intensifier
JP7170714B2 (ja) 2018-04-04 2022-11-14 三菱電機株式会社 赤外線固体撮像装置
EP4269605A4 (en) * 2020-12-28 2024-11-20 Fujimori Kogyo Co., Ltd. BLOOD COAGULATION INSPECTION PROCEDURES
CN115219292B (zh) * 2022-06-09 2025-09-30 常熟常江生物技术有限公司 全自动血栓弹力图仪质控品及其制备方法、应用方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221614A (en) * 1988-03-03 1993-06-22 Nippon Shoji Kabushiki Kaisha Method and reagent for determining the biological activity of antithrombin III by measuring coagulation time
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
US5486599A (en) * 1989-03-29 1996-01-23 The Board Of Trustees Of The Leland Stanford Junior University Construction and use of synthetic constructs encoding syndecan
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
US5051357A (en) * 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
AU6403590A (en) * 1989-09-25 1991-04-18 Asahi Kasei Kogyo Kabushiki Kaisha Isolated, physiologically active human thrombomodulin polypeptide
ES2170747T3 (es) * 1990-08-15 2002-08-16 Paion Gmbh Analogos superiores de trombomodulina para uso farmaceutico.
IL100093A0 (en) * 1990-11-30 1992-08-18 Kowa Co Thrombin-binding substance and process for preparing the same
US5273962A (en) * 1990-11-30 1993-12-28 Kowa Co., Ltd. Human urinary thrombomodulin with a modified glycosaminoglycan (GAG) binding site
AU2870992A (en) * 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
SE470274B (sv) * 1991-11-13 1993-12-20 Bjoern Dahlbaeck Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
FR2689640B1 (fr) * 1992-04-06 1997-08-08 Bio Merieux Procede pour la determination d'une activite proteine c et/ou proteine s dans un echantillon plasmatique.
DE4229933A1 (de) * 1992-09-08 1994-03-10 Max Planck Gesellschaft Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern
DE4427785A1 (de) * 1994-08-08 1996-02-15 Behringwerke Ag Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
EP0711838B2 (de) * 1994-11-10 2007-06-20 Dade Behring Marburg GmbH Verfahren zum spezifischen Nachweis eines aktivierten Gerinnungsfaktors V mit einer erhöhten Stabilität gegenüber aktiviertem Protein C

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022852A3 (en) * 2000-09-13 2003-04-10 Affinity Biolog Inc Method for measuring antithrombin activity
WO2014020183A1 (de) 2012-08-03 2014-02-06 Ici Immunochemical Intelligence Gmbh In-vitro-assay zur diagnose von störungen der hämostase

Also Published As

Publication number Publication date
US20020019021A1 (en) 2002-02-14
EP0915340B1 (de) 2006-01-04
AU751525B2 (en) 2002-08-22
CA2252983A1 (en) 1999-05-07
JPH11225796A (ja) 1999-08-24
ATE315233T1 (de) 2006-02-15
CA2252983C (en) 2010-07-13
EP0915340A1 (de) 1999-05-12
US20030207343A1 (en) 2003-11-06
ES2255121T3 (es) 2006-06-16
AU9139798A (en) 1999-05-27
DE59813326D1 (de) 2006-03-30
JP4361980B2 (ja) 2009-11-11

Similar Documents

Publication Publication Date Title
EP0915340B1 (de) Verfahren zur Bestimmung des antikoagulatorischen Potentials einer Probe und Verfahren zur Bestimmung der Glykosilierung von Thrombomodulin
DE60024669T2 (de) Hämatologische bestimmung und reagenz
DE69108896T2 (de) Verfahren zur bestimmung der konzentration von antikoagulantien.
EP0236985B1 (de) Verfahren zur photometrischen Bestimmung der Protein C- und/oder Protein S-Aktivität
EP0711838B2 (de) Verfahren zum spezifischen Nachweis eines aktivierten Gerinnungsfaktors V mit einer erhöhten Stabilität gegenüber aktiviertem Protein C
EP0696642B1 (de) Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
EP1059359B1 (de) Verfahren zur Bestimmung der Aktivität der Faktor VII-aktivierenden Protease aus Proteinlösungen
DE102005028018A1 (de) Verfahren zur Standardisierung von Gerinnungstesten
DE3536903A1 (de) Verfahren zur photometrischen bestimmung von protein c
EP0656424B1 (de) Test zur Bestimmung der Empfindlichkeit gegenüber aktiviertem Protein C
AT405692B (de) Reagens zur bestimmung der aptt
EP1752772A1 (de) Faktor Xa basiertes Heparin-Testverfahren unter Verwendung einer Heparin-modifizierenden Komponente
DE112006003476T5 (de) Verfahren und Systeme zum Nachweisen und Quantifizieren indirekter Thrombininhibitoren
EP0445626B1 (de) Funktioneller Test zur Bestimmung der Protein S-Aktivität
EP0711839B1 (de) Kalibrator zur Verwendung in Testverfahren zum Nachweis eines defekten Gerinnungsfaktors V
EP0182929A1 (de) Koaktivator zur Aktivierung von Protein C
EP0977995B1 (de) Verfahren zum funktionellen nachweis von störungen im protein c-system
EP0570355B1 (de) Verwendung von Prothrombinfragmenten
DE3783840T2 (de) Verfahren zur bestimmung von plasma-protein und testsatz dafuer.
EP1853925A1 (de) Verfahren zur bestimmung der gesamtgerinnungsaktivität einer blut- oder plasmaprobe
DE19506263A1 (de) Verfahren zum spezifischen Nachweis eines Gerinnungsfaktors V mit einer erhöhten Stabilität gegenüber aktiviertem Protein C im aktivierten Zustand
DE10016139A1 (de) Verfahren zur Bestimmung von löslichem Fibrin
WO2014020183A1 (de) In-vitro-assay zur diagnose von störungen der hämostase
DD250187A5 (de) Verfahren zur photometrischen Bestimmung von Protein C

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8131 Rejection